DaVita Kidney Care has named George R. Aronoff, MD, MS, FACP, as vice president of clinical affairs for its U.S. hemodialysis operations and member of the Office of the Chief Medical Officer on DaVita Kidney Care’s physician leadership team.

He was chief medical officer Renal Ventures Management LLC (RVM) for four years.  This month, DaVita acquired all of RVM’s 38 clinics for $415 million.

Aronoff served as Chief of the Division of Nephrology and Hypertension at the University of Louisville School of Medicine. His academic research focused on individualization of drug therapy in patients with decreased kidney function. Members of his laboratory have explored the use of artificial intelligence in the dosing of drugs used to treat anemia in dialysis patients.

He graduated from Indiana University with a Bachelor of Arts degree in chemistry and received his Doctor of Medicine from Indiana University School of Medicine, where he also completed a Master of Science degree in pharmacology and his training in internal medicine and nephrology.

Aronoff has served on the board of directors for both the Renal Physician Association and the Kidney Health Initiative, a public‐private partnership of the American Society of Nephrology and the U.S. Food and Drug Administration.